MAKI Kazuhiro | Department of Hematology and Oncology, Dokkyo Medical University School of Medicine
スポンサーリンク
概要
- MAKI Kazuhiroの詳細を見る
- 同名の論文著者
- Department of Hematology and Oncology, Dokkyo Medical University School of Medicineの論文著者
関連著者
-
MAKI Kazuhiro
Department of Hematology and Oncology, Dokkyo Medical University School of Medicine
-
MITANI Kinuko
Department of Hematology and Oncology, Dokkyo Medical University School of Medicine
-
Mitani Kinuko
Department Of Hematology Dokkyo Medical University
-
MITANI Kinuko
Department of Hematology, Dokkyo University School of Medicine
-
MAKI Kazuhiro
Department of Hematology, Dokkyo Medical University School of Medicine
-
Maki Kazuhiro
Department Of Hematology Dokkyo Medical University School Of Medicine
-
Miyazawa Keisuke
Department Of Hematology Tokyo Medical University
-
Maki Kazuhiro
Department Of Hematology Dokkyo University School Of Medicine
-
Sasaki Ko
Department Of Agricultured Chemistry Faculty Of Agriculture Tohoku University
-
Yamagata Tetsuya
Dokkyo Medical Univ. School Of Medicine Tochigi‐ken Jpn
-
NAKAMURA Yuka
Department of Biomolecular Engineering, Graduate School of Engineering, Tohoku University
-
YAMAGATA Tetsuya
Department of Polymer Science and Engineering,Faculty of Textile Science,Kyoto Institute of Technolo
-
Yamagata Tetsuya
Department Of Hematology Dokkyo Medical University School Of Medicine
-
Nakamura Yuka
Department Of Biotechnology Graduate School Of Engineering Nagoya University
-
SUGITA Fusako
Department of Hematology and Oncology, Dokkyo Medical University School of Medicine
-
Yamagata Tetsuya
Department of Geriatric Dentistry, Showa University, School of Dentistry
-
Shimizu Ritsuko
Institute Of Basic Medical Sciences And Center For Tara University Of Tsukuba
-
Eguchi Mariko
Department of Internal Medicine, Kitasato University School of Medicine
-
Eguchi Mariko
獨協医科大学 医学部血液内科学
-
Eguchi Mariko
Department Of Hematology Dokkyo Medical University School Of Medicine
-
Nakamura Yuka
Department Of Chemical Engineering Nara National College Of Technology
-
EGUCHI ISHIMAE
Department of Hematology, Dokkyo Medical University School of Medicine
-
PORCHER Catherine
MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford
-
YAMAMOTO Masayuki
Medical Biochemistry, Tohoku University School of Medicine
-
Porcher Catherine
Mrc Molecular Haematology Unit Weatherall Institute Of Molecular Medicine University Of Oxford
-
Eguchi Mariko
Department Of Cancer Cytogenetics Division Of Molecular Biology Research Institute For Radiation Bio
-
Sasaki Keiko
Central Research Laboratory Hitachi Ltd.
-
Sasaki Ko
Department Of Hematology Dokkyo Medical University School Of Medicine
-
Eguchi Ishimae
Department Of Hematology Dokkyo Medical University School Of Medicine
-
KITABAYASHI Issay
Molecular Oncology Division, National Cancer Center Research Institute
-
YAMAGATA Tetsuya
Section on Immunology and Immunogenetics, Joslin Diabetes Center, Harvard Medical School
-
TOKITA Katsuya
Department of Hematology, Dokkyo Medical University School of Medicine
-
Mitani Kinuko
Department Of Hematology Dokkyo Medical University School Of Medicine
-
Tokita Katsuya
Department Of Hematology Dokkyo Medical University School Of Medicine
-
Kitabayashi Issay
Molecular Oncology Division National Cancer Center Research Institute
-
Nakamura Yuka
Department Of Hematology Dokkyo Medical University School Of Medicine
-
Yamamoto Masayuki
Medical Biochemistry Tohoku University School Of Medicine
-
Kitabayashi Issay
National Cancer Center Res. Inst. Tokyo Jpn
-
SASAKI Ko
Department of Hematology and Oncology, Dokkyo Medical University School of Medicine
-
NAKAMURA Yuka
Department of Hematology and Oncology, Dokkyo Medical University School of Medicine
著作論文
- Role of the RUNX1-EVI1 fusion gene in leukemogenesis
- RUNX1/EVI1, which blocks myeloid differentiation, inhibits CCAAT-enhancer binding protein α function
- Leukemia-related transcription factor TEL/ETV6 expands erythroid precursors and stimulates hemoglobin synthesis
- TEL/ETV6 Binds to Corepressor KAP1 via the HLH Domain
- Runx1/AML1 in Normal and Abnormal Hematopoiesis
- Acute myeloid leukemia with t(7;21)(q11.2;q22) expresses a novel, reversed-sequence RUNX1-DTX2 chimera
- Fadd and Skp2 are possible downstream targets of RUNX1-EVI1